Clinical trial NCT06842316
Status: RecruitingObservational studyLatest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
- Record number
- NCT06842316
- Status
- Recruiting
- Type and phase
- Observational study
- Participants
- Target: 100
- Condition (as registered)
- Inflammatory Disorder of Immune System, Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Psoriatic, Inflammatory Bowel Diseases, Sjogren's Syndrome, Lupus Erythematosus, Systemic
- Countries
- France
- Topic in the guide
- Arthritis and Osteoarthritis, Crohn’s and Ulcerative Colitis, Skin Conditions
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: April 10, 2025
- End of data collection for primary results: April 9, 2027 (expected)
- Trial completion: April 9, 2027 (expected)
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Arthritis and Osteoarthritis: ongoing trials · Crohn’s and Ulcerative Colitis: ongoing trials · Skin Conditions: ongoing trials · Thinking of taking part? Which specialist to see